The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Regulation of hypoxia-inducible factor 1α is mediated by an O 2 -dependent degradation domain via the ubiquitin-proteasome pathway
Open accessAbstract
Hypoxia induces a group of physiologically important genes such as erythropoietin and vascular endothelial growth factor. These genes are transcriptionally up-regulated by hypoxia-inducible factor 1 (HIF-1), a global regulator that belongs to the basic helix-loop-helix PAS family. Although HIF-1 is a heterodimer composed of α and β subunits, its activity is primarily determined by hypoxia-induced stabilization of HIF-1α, which is otherwise rapidly degraded in oxygenated cells. We report the identification of an oxygen-dependent degradation (ODD) domain within HIF-1α that controls its degradation by the ubiquitin-proteasome pathway. The ODD domain consists of ≈200 amino acid residues, located in the central region of HIF-1α. Because portions of the domain independently confer degradation of HIF-1α, deletion of this entire region is required to give rise to a stable HIF-1α, capable of heterodimerization, DNA-binding, and transactivation in the absence of hypoxic signaling. Conversely, the ODD domain alone confers oxygen-dependent instability when fused to a stable protein, Gal4. Hence, the ODD domain plays a pivotal role for regulating HIF-1 activity and thereby may provide a means of controlling gene expression by changes in oxygen tension.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“at moderate levels, ROS induce transcription of HIF1α, the founding member of the family of hypoxia-induced factors, and stabilize the encoded protein, which is normally hydroxylated within less than 5 min, by inhibiting the activity of the iron-dependent prolyl 4-hydroxylase (PHD) involved in its degradation29.”
From ROS in cancer therapy: the bright side of the moon (2020) · cites this paper as [29]
Experimental — accuracy not yet measuredIn the citing paper
“One or more of the Fe-S centers is a likely source (135, 160, 251), although the ubisemiquinone (QH•) binding site (143, 160, 200), or the flavin complex (216), per se, could also be sources”
From Mitochondrial reactive oxygen species production in excitable cells: Modulators of mitochondrial and cell function (2009) · cites this paper as [160]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S. N., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,836
Semenza, G. L., & Wang, G. L. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.12.5447 · Cited by 2,617
Amino Acid Sequences Common to Rapidly Degraded Proteins: The PEST Hypothesis
Rogers, S. W., Wells, R., & Rechsteiner, M. (1986) · Science · doi:10.1126/science.2876518 · Cited by 2,541
Rock, K. L., Gramm, C., Rothstein, L., Clark, K., Stein, R., Dick, L., Hwang, D., & Goldberg, A. L. (1994) · Cell · doi:10.1016/s0092-8674(94)90462-6 · Cited by 2,524
STRUCTURE AND FUNCTIONS OF THE 20S AND 26S PROTEASOMES
Coux, O., Tanaka, K., & Goldberg, A. L. (1996) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.65.070196.004101 · Cited by 2,438
The ubiquitin-proteasome proteolytic pathway
Ciechanover, A. J. (1994) · Cell · doi:10.1016/0092-8674(94)90396-4 · Cited by 1,804
PEST sequences and regulation by proteolysis
Rechsteiner, M., & Rogers, S. W. (1996) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(96)10031-1 · Cited by 1,707
Salceda, S., & Caro, J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.36.22642 · Cited by 1,674
The Aryl Hydrocarbon Receptor Complex
Hankinson, O. (1995) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.35.040195.001515 · Cited by 1,649
Flagged first, then by citations
Research works printed but not linked: 2
- 10.1128/mcb.12.12.5447-5454.1992 · DOI · Paper page
- 10.1128/mcb.14.9.6075-6086.1994 · DOI
Cited by
Sorted by citations
Items 101–200 of 1,002
Mammalian Oxygen Sensing, Signalling and Gene Regulation
Wenger, R. H. (2000) · Journal of Experimental Biology · doi:10.1242/jeb.203.8.1253 · Cited by 444
Sodhi, A., Montaner, S., Patel, V., Zohar, M., Bais, C., Mesri, E. A., & Gutkind, J. S. (2000) · PubMed · Cited by 452
Furuta, G. T., Turner, J. R., Taylor, C. T., Hershberg, R. M., Comerford, K., Narravula, S., Podolsky, D. K., & Colgan, S. P. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.9.1027 · Cited by 449
Bruick, R. K. (2003) · Genes & Development · doi:10.1101/gad.1145503 · Cited by 446
Familial Alzheimer's disease: Site of mutation influences clinical phenotype
Lippa, C. F., Swearer, J. M., Kane, K., Nochlin, D., Bird, T. D., Ghetti, B. F., Nee, L. E., George‐Hyslop, P. S., Pollen, D. A., & Drachman, D. A. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200009)48:3 · Cited by 67
Intracellular localisation of human HIF-1α hydroxylases:implications for oxygen sensing
Metzen, E., Berchner-Pfannschmidt, U., Stengel, P., Marxsen, J. H., Stolze, I., Klinger, M., Huang, W. Q., Wotzlaw, C., Hellwig-Bürgel, T., Jelkmann, W., et al. (2003) · Journal of Cell Science · doi:10.1242/jcs.00318 · Cited by 432
The ever-expanding role of HIF in tumour and stromal biology
LaGory, E. L., & Giaccia, A. J. (2016) · Nature Cell Biology · doi:10.1038/ncb3330 · Cited by 445
Role and regulation of prolyl hydroxylase domain proteins
Fong, G.-H., & Takeda, K. (2008) · Cell Death and Differentiation · doi:10.1038/cdd.2008.10 · Cited by 437
Wadia, J. S., & Dowdy, S. F. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.10.005 · Cited by 430
Activation of the HIF pathway in cancer
Maxwell, P. H. (2001) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(00)00193-3 · Cited by 430
Nillesen, S. T. M., Geutjes, P. J., Wismans, R. G., Schalkwijk, J., Daamen, W. F., & Kuppevelt, T. H. V. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.10.029 · Cited by 420
The roles of tumor-associated macrophages in tumor angiogenesis and metastasis
Fu, L., Du, W., Cai, M., Yao, J., Zhao, Y., & Mou, X. (2020) · Cellular Immunology · doi:10.1016/j.cellimm.2020.104119 · Cited by 426
Nitric Oxide Impairs Normoxic Degradation of HIF-1α by Inhibition of Prolyl Hydroxylases
Metzen, E., Zhou, J., Jelkmann, W., Fandrey, J., & Brüne, B. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-12-0791 · Cited by 414
Bergeron, M., Yu, A. Y., Solway, K., Semenza, G. L., & Sharp, F. R. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00845.x · Cited by 410
Xia, X., Lemieux, M. E., Li, W., Carroll, J. S., Brown, M., Liu, X. S., & Kung, A. L. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810067106 · Cited by 410
Hypoxia-Inducible Factor-1 Is Central to Cardioprotection
Eckle, T. D. L. G., Köhler, D., Lehmann, R., Kasmi, K. C. E., & Eltzschig, H. K. (2008) · Circulation · doi:10.1161/circulationaha.107.758516 · Cited by 410
Altmann, C., & Schmidt, M. H. H. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010110 · Cited by 413
Nakayama, K., Frew, I. J., Hagensen, M. K., Skals, M., Habelhah, H., Bhoumik, A., Kadoya, T., Erdjument‐Bromage, H., Tempst, P., Frappell, P. B., et al. (2004) · Cell · doi:10.1016/j.cell.2004.06.001 · Cited by 406
Angiogenesis in the atherosclerotic plaque
Camaré, C., Pucelle, M., Nègre-Salvayre, A., & Salvayre, R. (2017) · Redox Biology · doi:10.1016/j.redox.2017.01.007 · Cited by 401
Reversible Inactivation of HIF-1 Prolyl Hydroxylases Allows Cell Metabolism to Control Basal HIF-1
Lu, H., Dalgard, C. L., Mohyeldin, A., McFate, T., Tait, A. S., & Verma, A. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508718200 · Cited by 400
Forristal, C. E., Wright, K. L., Hanley, N. A., Oreffo, R. O. C., & Houghton, F. D. (2009) · Reproduction · doi:10.1530/rep-09-0300 · Cited by 409
Krieg, M., Haas, R., Brauch, H., Acker, T., Flamme, I., & Plate, K. H. (2000) · Oncogene · doi:10.1038/sj.onc.1203938 · Cited by 396
Functional role of p35srj, a novel p300/CBP binding protein, during transactivation by HIF-1Preprint
Bhattacharya, S., Michels, C. L., Leung, M.-K., Arany, Z. P., Kung, A. L., & Livingston, D. M. (1999) · Genes & Development · doi:10.1101/gad.13.1.64 · Cited by 397
Cellular oxygen sensing by mitochondria: old questions, new insight
Chandel, N. S., & Schumacker, P. T. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.88.5.1880 · Cited by 389
Carrero, P., Okamoto, K., Coumailleau, P., O’Brien, S. L., Tanaka, H., & Poellinger, L. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.1.402-415.2000 · Cited by 386
PR39, a peptide regulator of angiogenesis
Li, J., Post, M. J., Volk, R., Gao, Y., Li, M., Métais, C., Sato, K., Tsai, J. C., Aird, W. C., ROSENBERG, R. D., et al. (2000) · Nature Medicine · doi:10.1038/71527 · Cited by 384
Hyperglycemia Regulates Hypoxia-Inducible Factor-1α Protein Stability and Function
Catrina, S., Okamoto, K., Pereira, T., Brismar, K., & Poellinger, L. (2004) · Diabetes · doi:10.2337/diabetes.53.12.3226 · Cited by 392
Identification of a hypoxia response element in the transferrin receptor gene
Lok, C. N., & Ponka, P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.34.24147 · Cited by 380
ERK activation upon hypoxia: involvement in HIF‐1 activation
Minet, E., Arnould, T., Michel, G., Roland, I., Mottet, D., Raes, M. J., Remacle, J., & Michiels, C. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01181-9 · Cited by 380
Molecular Biology of Erythropoietin
JELKMANN, W. E. B. (2004) · Internal Medicine · doi:10.2169/internalmedicine.43.649 · Cited by 384
Bar, E. E., Lin, A., Mahairaki, V., Matsui, W., & Eberhart, C. G. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.091021 · Cited by 373
Similarities and Distinctions of Cancer and Immune Metabolism in Inflammation and Tumors
Andrejeva, G., & Rathmell, J. C. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.06.004 · Cited by 374
MAPK Signaling Up-regulates the Activity of Hypoxia-inducible Factors by Its Effects on p300
Sang, N., Stiehl, D. P., Bohensky, J., Leshchinsky, I., Srinivas, V., & Caro, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209702200 · Cited by 370
Minchenko, О. H., Leshchinsky, I., Opentanova, I., Sang, N., Srinivas, V., Armstead, V. E., & Caro, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110978200 · Cited by 376
Mucosal Protection by Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibition
Robinson, A., Keely, S., Karhausen, J., Gerich, M. E., Furuta, G. T., & Colgan, S. P. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.09.033 · Cited by 368
Erythropoietin after a century of research: younger than ever
JELKMANN, W. E. B. (2007) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2007.00818.x · Cited by 371
Garvey, J., Taylor, C. T., & McNicholas, W. T. (2009) · European Respiratory Journal · doi:10.1183/09031936.00111208 · Cited by 367
HIF-1–dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia
Eltzschig, H. K., ABDULLA, P. R., Hoffman, E., Hamilton, K. E., Daniels, D., Schönfeld, C., Löffler, M., Reyes, G., Duszenko, M., Karhausen, J., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050177 · Cited by 352
The transcriptional factors HIF-1 and HIF-2 and their novel inhibitors in cancer therapy
Albadari, N. G., Deng, S., & Li, W. (2019) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2019.1613370 · Cited by 365
Baranova, O., Miranda, L. F., Pichiule, P., Dragatsis, I., Johnson, R. S., & Chavez, J. C. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0449-07.2007 · Cited by 350
(2002) · PubMed · Cited by 349
HIF-1α Induces Genetic Instability by Transcriptionally Downregulating MutSα Expression
Koshiji, M., To, K. K.-W., Hammer, S., Kumamoto, K., Harris, A. L., Modrich, P., & Huang, L. E. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.02.015 · Cited by 346
Airley, R. E., & Mobasheri, A. (2007) · Chemotherapy · doi:10.1159/000104457 · Cited by 342
HIF‐dependent induction of adenosine A2B receptor in hypoxia
Kong, T., Westerman, K. A., Faigle, M., Eltzschig, H. K., & Colgan, S. P. (2006) · The FASEB Journal · doi:10.1096/fj.06-6419com · Cited by 338
Regulation of the Erythropoietin Gene
Ebert, B. L., & Bunn, H. F. (1999) · Blood · doi:10.1182/blood.v94.6.1864 · Cited by 338
Self-citationMitochondrial reactive oxygen species regulate hypoxic signaling
Hamanaka, R. B., & Chandel, N. S. (2009) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.08.005 · Cited by 332
McMahon, S., Charbonneau, M., Grandmont, S., Richard, D. E., & Dubois, C. M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604507200 · Cited by 335
Generating specificity and diversity in the transcriptional response to hypoxia
Lendahl, U., Lee, K. L., Yang, H. H., & Poellinger, L. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2665 · Cited by 333
Oxygen sensors and angiogenesis
Maxwell, P. H., & Ratcliffe, P. J. (2002) · Seminars in Cell and Developmental Biology · doi:10.1006/scdb.2001.0287 · Cited by 333
Carbia-Nagashima, A., Gerez, J., Perez-Castro, C., Paez-Pereda, M., Silberstein, S., Stalla, G. K., Holsboer, F., & Arzt, E. (2007) · Cell · doi:10.1016/j.cell.2007.07.044 · Cited by 318
Konecny, G. E., Meng, Y. G., Untch, M., Wang, H.-J., Bauerfeind, I., Epstein, M. S., Stieber, P., Vernes, J.-M., Gutierrez, J., Hong, K., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0951-3 · Cited by 318
Vincent, K. A., Shyu, K., Luo, Y., Magner, M., Tio, R. A., Jiang, C., Goldberg, M. A., Akita, G. Y., Gregory, R. J., & Isner, J. M. (2000) · Circulation · doi:10.1161/01.cir.102.18.2255 · Cited by 314
Krishnan, J., Danzer, C. F., Simka, T., Ukropec, J., Walter, K., Kumpf, S., Mirtschink, P., Ukropcová, B., Gašperíková, D., Pedrazzini, T., et al. (2012) · Genes & Development · doi:10.1101/gad.180406.111 · Cited by 316
Hypoxia-inducible Factor and Its Biomedical Relevance
Huang, E. L., & Bunn, H. F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.r200030200 · Cited by 315
Self-citationWiesener, M. S., Münchenhagen, P., Berger, I., Morgan, N. V., Roigas, J., Schwiertz, A., Jürgensen, J. S., Gruber, G., Maxwell, P. H., Löning, S. A., et al. (2001) · PubMed · Cited by 308
Lahiri, S., Roy, A., Baby, S. M., Hoshi, T., Semenza, G. L., & Prabhakar, N. R. (2006) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2005.07.001 · Cited by 312
Koh, M. Y., Spivak-Kroizman, T., Venturini, S., Welsh, S., Williams, R. R., Kirkpatrick, D. L., & Powis, G. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0463 · Cited by 309
Mechanisms of hypoxia signalling: new implications for nephrology
Schödel, J., & Ratcliffe, P. J. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0182-z · Cited by 309
Wang, V., Davis, D. A., Haque, M., Huang, E. L., & Yarchoan, R. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4130 · Cited by 317
Huang, J., Zhao, Q., Mooney, S. M., & Lee, F. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206955200 · Cited by 307
Davarinos, N. A., & Pollenz, R. S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.40.28708 · Cited by 325
Safran, M., Kim, W. Y., O'Connell, F., Flippin, L., Günzler, V., Horner, J. W., DePinho, R. A., & Kaelin, W. G. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509459103 · Cited by 305
Rivard, A., Berthou-Soulié, L., Principe, N., Kearney, M., Curry, C., Branellec, D., Semenza, G. L., & Isner, J. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001029200 · Cited by 301
Copper Regulation of Hypoxia-Inducible Factor-1 Activity
Feng, W., Ye, F., Xue, W., Zhou, Z., & Kang, Y. J. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.051516 · Cited by 309
Tumor hypoxia and cancer progression
Zhou, J., Schmid, T., Schnitzer, S. E., & Brüne, B. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.05.028 · Cited by 305
Elson, D. A., Thurston, G., Huang, E. L., Ginzinger, D. G., McDonald, D. M., Johnson, R. S., & Arbeit, J. M. (2001) · Genes & Development · doi:10.1101/gad.914801 · Cited by 297
Sutter, T. R., Laughner, E., & Semenza, G. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.080072497 · Cited by 299
Regulation of the Erythropoietin Gene
Imagawa, S., Goldberg, M. A., & Bunn, H. F. (1989) · Advances in experimental medicine and biology · doi:10.1007/978-1-4613-0623-8_9 · Cited by 298
Self-citationLee, Y. M., Jeong, C., Koo, S.-Y., Son, M. J., Song, H. S., Bae, S., Raleigh, J. A., Chung, H., Yoo, M., & Kim, K. (2001) · Developmental Dynamics · doi:10.1002/1097-0177(20010201)220:2 · Cited by 298
Reactive oxygen species in the control of hypoxia-inducible factor-mediated gene expression
Kietzmann, T., & Görlach, A. (2005) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2005.03.010 · Cited by 295
Oxygen sensing and hypoxia signalling pathways in animals: The implications of physiology for cancer
Ratcliffe, P. J. (2013) · The Journal of Physiology · doi:10.1113/jphysiol.2013.251470 · Cited by 294
Inhibition of Hypoxia-inducible Factor 1 Activation by Carbon Monoxide and Nitric Oxide
Huang, E. L., Willmore, W. G., Gu, J., Goldberg, M. A., & Bunn, H. F. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.13.9038 · Cited by 288
Self-citationAerotaxis and Other Energy-Sensing Behavior in Bacteria
Taylor, B. L., Zhulin, I. B., & Johnson, M. S. (1999) · Annual Review of Microbiology · doi:10.1146/annurev.micro.53.1.103 · Cited by 290
Hypoxia Up-regulates Prolyl Hydroxylase Activity
D’Angelo, G., Duplan, E., Boyer, N., Vigne, P., & Frelin, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302244200 · Cited by 294
Negative and positive regulation of HIF-1: A complex network
Bárdos, J. I., & Ashcroft, M. A. (2005) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2005.05.001 · Cited by 287
Hara, S., Hamada, J., Kobayashi, C., Kondo, Y., & Imura, N. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5659 · Cited by 294
Energy metabolism in adult neural stem cell fate
Rafalski, V. A., & Brunet, A. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.10.007 · Cited by 294
The Roles of Hypoxia in the In Vitro Engineering of Tissues
Malda, J., Klein, T. J., & Upton, Z. (2007) · Tissue Engineering · doi:10.1089/ten.2006.0417 · Cited by 282
Hypoxia induced EMT: A review on the mechanism of tumor progression and metastasis in OSCC
Joseph, J. P., Harishankar, M. K., Pillai, A. A., & Devi, A. (2018) · Oral Oncology · doi:10.1016/j.oraloncology.2018.03.004 · Cited by 282
Ebert, B. L., & Bunn, H. F. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.7.4089 · Cited by 279
Self-citationHIF-1 mediates the Warburg effect in clear cell renal carcinoma
Semenza, G. L. (2007) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-007-9081-2 · Cited by 281
Angiogenesis: How a Tumor Adapts to Hypoxia
Richard, D. E., Berra, E., & Pouysségur, J. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1889 · Cited by 278
Role of hypoxia-inducible factor in cell survival during myocardial ischemia–reperfusion
Loor, G., & Schumacker, P. T. (2008) · Cell Death and Differentiation · doi:10.1038/cdd.2008.13 · Cited by 280
Oxygen-dependent diseases in the retina: Role of hypoxia-inducible factors
Arjamaa, O., & Nikinmaa, M. (2006) · Experimental Eye Research · doi:10.1016/j.exer.2006.01.016 · Cited by 275
Obach, M., Navarro‐Sabaté, À., Caro, J., Kong, X., Duran, J., Gómez, M., Perales, J. C., Ventura, F., Rosa, J. L., & Bartrons, R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406096200 · Cited by 274
Physiological activation of hypoxia inducible factor‐1 in human skeletal muscle
Ameln, H., Gustafsson, T., Sundberg, C. J., Okamoto, K., Jansson, E., Poellinger, L., & Makino, Y. (2005) · The FASEB Journal · doi:10.1096/fj.04-2304fje · Cited by 276
Hypoxia, gene expression, and metastasis
Chan, D. A., & Giaccia, A. J. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9063-1 · Cited by 280
Interplay between HDAC3 and WDR5 Is Essential for Hypoxia-Induced Epithelial-Mesenchymal Transition
Wu, M.-Z., Tsai, Y., Yang, M., Huang, C.-H., Chang, S., Chang, C., Teng, S., & Wu, K.-J. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.07.012 · Cited by 274
Elvert, G., Kappel, A., Heidenreich, R., Englmeier, U., Lanz, S., Acker, T., Rauter, M., Plate, K. H., Sieweke, M. H., Breier, G., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211298200 · Cited by 275
Hypoxia modulated gene expression: angiogenesis, metastasis and therapeutic exploitation
Dachs, G. U., & Tozer, G. M. (2000) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00159-3 · Cited by 272
Regulation of Angiogenesis by Hypoxia and Hypoxia‐Inducible Factors
Hickey, M. M., & Simon, M. C. (2006) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/s0070-2153(06)76007-0 · Cited by 273
(2001) · PubMed · Cited by 270
Turner, K., Moore, J. W., Jones, A., Taylor, C., Cuthbert-Heavens, D., Cheng, H., Leek, R., Gatter, K. C., Maxwell, P. H., Ratcliffe, P. J., et al. (2002) · PubMed · Cited by 265
mTORC1 Signaling under Hypoxic Conditions Is Controlled by ATM-Dependent Phosphorylation of HIF-1α
Cam, H., Easton, J. B., High, A., & Houghton, P. J. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.10.030 · Cited by 266
The human side of hypoxia‐inducible factor
Smith, T. G., Robbins, P. A., & Ratcliffe, P. J. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07029.x · Cited by 270
Pescador, N., Villar, D., Cifuentes, D., Garcı́a-Rocha, M., Ortiz-Barahona, A., Vázquez, S., Ordóñez, Á., Cuevas, Y., Saez-Morales, D., García‐Bermejo, L., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009644 · Cited by 265
Ball, M. K., Waypa, G. B., Mungai, P. T., Nielsen, J. M., Czech, L., Dudley, V. J., Beussink‐Nelson, L., Dettman, R. W., Berkelhamer, S. K., Steinhorn, R. H., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201302-0302oc · Cited by 262
Accumulation of HIF-1α under the influence of nitric oxide
Sandau, K. B., Fandrey, J., & Brüne, B. (2001) · Blood · doi:10.1182/blood.v97.4.1009 · Cited by 263
Garayoa, M., Martı́nez, A., Lee, S., Pı́o, R., An, W. G., Neckers, L., Trepel, J. B., Montuenga, L. M., Ryan, H. E., Johnson, R. S., et al. (2000) · Molecular Endocrinology · doi:10.1210/mend.14.6.0473 · Cited by 265
HIF-1α controls extracellular matrix synthesis by epiphyseal chondrocytes
Pfander, D., Cramer, T., Schipani, E., & Johnson, R. S. (2003) · Journal of Cell Science · doi:10.1242/jcs.00385 · Cited by 261
Metadata
- Authors
- Huang, L. E., Gu, J., Schau, M., & Bunn, H. F.
- Affiliations
- Division of Hematology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115
- Brigham and Women's Hospital (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 1998-07-07
- Volume
- 95
- Issue
- 14
- Pages
- 7987-7992
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC20916
- OpenAlex
- W2075054245
- Cited by
- 2,113
- References
- 40
- Citations by year
- 2026: 36 · 2025: 36 · 2024: 39 · 2023: 43 · 2022: 49 · 2021: 56 · 2020: 49 · 2019: 60 · 2018: 59 · 2017: 56 · 2016: 70 · 2015: 65 · 2014: 78 · 2013: 92 · 2012: 74
- FWCI
- 28.30
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK041234, R0-DK41234, F32-DK09365, F32DK009365)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Keywords
- hypoxia-inducible factor-1α, oxygen-dependent degradation domain, ubiquitin-proteasome system, protein degradation, hypoxia, oxygen sensing, transcriptional regulation, erythropoietin, vascular endothelial growth factor
- MeSH terms
- Animals, Cell Line, Cysteine Endopeptidases, DNA, DNA-Binding Proteins, Multienzyme Complexes, Nuclear Proteins, Oxygen, Protein Binding, Transcription Factors, Ubiquitins, Signal Transduction, Cell Hypoxia, Dimerization, Proteasome Endopeptidase Complex, Hypoxia-Inducible Factor 1, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review